User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 5 results.
    • Journal article
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Journal article
    Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS
    Caillot, D. Bassaris, H McGeer, A Arthur, C Prentice, HG. Seifert, W De Beule, K (2001) Clinical Infectious Diseases — Vol. 33, no. 8, p. E83-E90 (2001)
    • Speech
    Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma
    Harousseau, J. L. Avet-Loiseau, H. Mary, J. Facon, T. Attal, M. Doyen, Chantal[UCL] Hulin, C. Garderet, L. Tiab, M. Lepeu, G. Araujo, C. Caillot, D. Petillon, M. Mathiot, C. Moreau, P. (2010) 15th Annual Meeting of the European-Hematology-Association — Barcelona(Spain)
    • Journal article
    Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial
    Ferme, C Ferrant, Augustin[UCL] Sebban, C. Hennequin, C Divine, M. Lederlin, P. Gabarre, J Caillot, D. Bordessoule, D. Brice, P. Moullet, I Berger, F. Lepage, E. (2000) Blood — Vol. 95, no. 7, p. 2246-2252 (2000)
    • Journal article
    Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
    Moreau, P. Attal, M. Garban, F. Hulin, C. Facon, T. Marit, G. Michallet, M. Doyen, Chantal[UCL] Leyvraz, S. Mohty, M. Wetterwald, M. Mathiot, C. Caillot, D. Berthou, C. Benboubker, L. Garderet, L. Chaleteix, C. Traullé, C. Fuzibet, J. G. Jaubert, J. Lamy, T. Casassus, P. Dib, M. Kolb, B. Dorvaux, V. Grosbois, B. Yakoub-Agha, I. Harousseau, J. L. Avet-Loiseau, H. SAKK IFM Group (2007) Leukemia — Vol. 21, no.9, p. 2020-2024 (2007)